Antimicrobial prospect of newly synthesized 1,3-thiazole derivatives

Molecules

Volumn 16, Issue 11, 2011, Pages 9386-9396

  Sadek, Bassem ^a   Al Tabakha, Moawia Mohammad ^b   Fahelelbom, Khairi Mustafa Salem ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b AL AIN UNIVERSITY   (United Arab Emirates)

Author keywords

1,3 thiazoles; Antimicrobial evaluation; benzo d thiazoles; Partition coefficient; Synthesis

Indexed keywords

ANTIINFECTIVE AGENT; THIAZOLE DERIVATIVE;

ARTICLE; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; FUNGUS; HUMAN; MICROBIOLOGICAL EXAMINATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-INFECTIVE AGENTS; BACTERIA; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 82255189882     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16119386     Document Type: Article

References (29)

1. Bayles, K.W. The bactericidal action of penicillin: New clues to an unsolved mystery. Trends Microbiol. 2000, 8, 274-278. (Pubitemid 30331001)
2. Carratala, J.; Alcaide, F.; Fernandez, S.A. Bacteremia due to viridans streptococci that are highly resistant to penicillin: Increase among neutropenic patients with cancer. Clin. Infect. Dis. 1995, 20, 1169-1173.
3. Sogn, D.D.; Evans, R.; Shepherd, G.M. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch. Intern. Med. 1992, 152, 1025-1032.
4. Haas, D.W.; Stratton, C.W.; Griffin, J.P.; Weeks, L.; Alls, S.C. Diminished Activity of Ceftizoxime in Comparison to Cefotaxime and Ceftriaxone Against Streptococcus pneumoniae. Clin. Infect. Dis. 1995, 20, 671-676.
5. John, C.C. Treatment Failure with Use of a Third-Generation Cephalosporin for Penicillin- Resistant Pneumococcal Meningitis: Case Report and Review. Clin. Infect. Dis. 1994, 18, 188-193. (Pubitemid 24055257)
6. Schaad, U.B.; Suter, S.; Gianella, A.B. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N. Engl. J. Med. 1990, 322, 141-147. (Pubitemid 20036386)
7. Bradshaw, T.D.; Westwell, A.D. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr. Med. Chem. 2004, 11, 1009-1021. (Pubitemid 38428650)
8. Hutchinson, I.; Jennings, S.A.; Vishnuvajjala, B.R.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4- aminophenyl)benzothiazole amino acid prodrugs. J. Med. Chem. 2002, 45, 744-747. (Pubitemid 34145721)
9. Hutchinson, I.; Chua, M.S.; Browne, H.L.; Trapani, V.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2- (4-aminophenyl)benzothiazoles. J. Med. Chem. 2001, 44, 1446-1455. (Pubitemid 32852121)
10. Kashiyama, E.; Hutchinson, I.; Chua, M.S.; Stinson, S.F.; Phillips, L.R.; Kaur, G.; Sausville, E.A.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl) benzothiazoles. J. Med. Chem. 1999, 42, 4172-4184. (Pubitemid 29483034)
11. Gong, B.Q.; Hong, F.; Kohm, C.; Bonham, L.; Klein, P. Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-beta. Bioorg. Med. Chem. Lett. 2004, 14, 1455-1459. (Pubitemid 38299428)
12. Hutchinson, I.; Bradshaw, T.D.; Matthews, C.S.; Stevens, M.F.G.; Westwell, A.D. Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues. Bioorg. Med. Chem. Lett. 2003, 13, 471-474. (Pubitemid 36259716)
13. Akbay, A.; Ören, I.; Arpaci, Ö.T.; Sener E.A.; Yalçin, I. Synthesis and HIV-1 Reverse Transcriptase Inhibitor Activity of Some 2,5,6-Substituted Benzoxazole, Benzimidazole, Benzothiazole and Oxazolo(4,5-b)pyridine Derivatives. Arzneimittel-Forsch. 2003, 53, 266-271. (Pubitemid 36535382)
14. Das, J.; Moquin, R.V.; Lin, J.; Liu, C.J.; Doweyko, A.M.; DeFex, H.F.; Fang, Q.; Pang, S.H.; Pitt, S.; Shen, D.R.; et al. Discovery of 2-amino-heteroarylbenzothiazole-6-anilides as potent p56(lck) inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 2587-2590. (Pubitemid 36830779)
15. Hays, S.J.; Rice, M.J.; Ortwine, D.F.; Johnson, G.; Schwarz, R.D.; Boyd, D.K.; Copeland, L.F.; Vartanian, M.G.; Boxer, P.A. Substituted 2-Benzothiazolamine as Sodium Flux Inhibitors- Quantitative Structure-Activity- Relationships and Anticonvulsant Activity. J. Pharm. Sci. 1994, 83, 1425-1432. (Pubitemid 24315278)
16. Foscolos, G.; Tsatsas, G.; Champagnac, A.; Pommier, M. Synthesis and pharmacodynamic study of new derivatives of benzothiazole. Ann. Pharm. Fr. 1977, 35, 295-307. (Pubitemid 8188373)
17. Paget, C.J.; Kisner, K.; Stone, R.L.; DeLong, D.C. Heterocyclic substituted ureas. II. Immunosuppressive and antiviral activity of benzothiazolyl- and benzoxazolylureas. J. Med. Chem. 1969, 12, 1016-1018.
18. Sadek, B.; Fahelelbom, K.M.S. Synthesis, Characterization, and Antimicrobial Evaluation of Oxadiazole Congeners. Molecules 2011, 16, 4339-4347.
19. Türkmen, H.; Ceyhan, N.; Ulkü Karabay Yavaolu, N.; Ozdemir, G.; Cetinkaya, B. Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a] pyridinium bromides with varying benzyl substituents. Eur. J. Med. Chem. 2011, 46, 2895-2900.
20. Li, F.; Mulyana, Y.; Feterl, M.; Warner, J.M.; Collins, J.G.; Keene, F.R. The antimicrobial activity of inert oligonuclear polypyridylruthenium(ii) complexes against pathogenic bacteria, including MRSA. Dalton Trans. 2011, 40, 5032-5038.
21. Fahelelbom, K.M.S.; Al-Tabakha, M. Quantitative structure activity relationship studies for new antimicrobial N2- substituted phenazines. Afr. J. Pharm. Pharmacol. 2009, 3, 47-50.
22. Podunavac-Kuzmanović, S.O.; Cvetković, D.D.; Barn, D.J. The effect of lipophilicity on the antibacterial activity of some 1-benzylbenzimidazole derivatives. J. Serb. Chem. Soc. 2008, 73, 967-978.
23. Vermin, G. General Synthesis Methods for Thiazole and Thiazolium Salts; Metzger, J.V., Ed.; Interscience: New York, NY, USA, 1979; Volume 34, pp. 165-335.
24. Yoshida, M.; Hayakawa, I.; Hayashi, N.; Agatsuma, T.; Oda, Y.; Tanzawa, F.; Iwasaki, S.; Koyama, K.; Furukawa, H.; Kurakata, S.; Sugano, Y. Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents. Bioorg. Med. Chem. Lett. 2005, 15, 3328-3332. (Pubitemid 40835729)
25. Mcomie, J.F.W.; Watts, M.L.; West, D.E. Demethylation of aryl methyl ethers by boron tribromide. Tetrahedron 1969, 24, 2289-2292.
26. Togashi, N.; Shiraishi, A.; Nishizaka, M.; Matsuoka, K.; Endo, K.; Hamashima, H.; Inoue, Y. Antibacterial activity of long-chain fatty alcohols against Staphylococcus aureus. Molecules 2007, 12, 139-148.
27. Greenberg, M.; Dodds, M.; Tian, M. Naturally occurring phenolic antibacterial compounds show effectiveness against oral bacteria by a quantitative structure-activity relationship study. J. Agric. Food Chem. 2008, 56, 11151-11156.
28. Barry, A.L. The Antimicrobial Susceptibility Test: Principle and Practices; Lea and Febiger: Philadelphia, PA, USA, 1976; p. 180.
29. Biol. Abstr., 64, 25183.